Cite
Pampín-Sánchez R, Barbazán-Vázquez FJ, Fernández-González B, et al. Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab. J Oncol Pharm Pract. 2021;27(4):1052doi: 10.1177/10781552211004680.
Pampín-Sánchez, R., Barbazán-Vázquez, F. J., Fernández-González, B., Rodríguez-de-Castro, B., Aparicio-Carreño, C., & Sampedro-Gimeno, T. (2021). Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 27(4), 1052. https://doi.org/10.1177/10781552211004680
Pampín-Sánchez, R, et al. "Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 27,4 (2021): 1052. doi: https://doi.org/10.1177/10781552211004680
Pampín-Sánchez R, Barbazán-Vázquez FJ, Fernández-González B, Rodríguez-de-Castro B, Aparicio-Carreño C, Sampedro-Gimeno T. Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab. J Oncol Pharm Pract. 2021 Jun;27(4):1052. doi: 10.1177/10781552211004680. Epub 2021 Mar 27. PMID: 33779367; PMCID: PMC8193621.
Copy
Download .nbib
